Psychiatric sequelae of phencyclidine abuse
- PMID: 10126
- DOI: 10.3109/15563657608988154
Psychiatric sequelae of phencyclidine abuse
Abstract
Phencyclidine use has been noted to produce a psychosis of several week's duration in a small fraction of users. Descriptions of the premorbid personalities of those who became psychotic resemble descriptions of LSD and marijuana users who experienced prolonged psychiatric difficulty. In addition, the psychosis produced can often be recognized as a "hallucinogen" psychosis. Certain features of the phencyclidine psychosis, namely the neurologic abnormalities, dose-related severity of symptoms, and regularity of the length of illness, are not noted with other psychedelic drugs, leading to the conclusion that PCP psychosis is a drug effect rather than a brief functional psychosis precipitated by the disintegrating PCP experience. However, the infrequent occurrence of psychosis in the (apparently) large exposed population still suggests that this is a combination of drug effect and vulnerable, pathologic personality.
Similar articles
-
The efficacy of ECT in phencyclidine-induced psychosis.J Clin Psychiatry. 1984 May;45(5):220-2. J Clin Psychiatry. 1984. PMID: 6144671
-
[Phencyclidine abuse, dependence, intoxication, and psychosis].Nihon Rinsho. 2010 Aug;68(8):1511-5. Nihon Rinsho. 2010. PMID: 20715485 Review. Japanese.
-
Time distortion in acute phencyclidine (PCP) psychosis. A correlation between 30 seconds estimation and urine drugs levels.Encephale. 1978;4(3):281-5. Encephale. 1978. PMID: 710364
-
The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users.NIDA Res Monogr. 1978 Aug;(21):183-200. NIDA Res Monogr. 1978. PMID: 101868 No abstract available.
-
[Phencyclidine, a drug which induces psychosis: its neuropharmacological actions].Yakubutsu Seishin Kodo. 1984 Sep;4(2):133-47. Yakubutsu Seishin Kodo. 1984. PMID: 6395556 Review. Japanese.
Cited by
-
Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats.Psychopharmacology (Berl). 1992;109(3):277-82. doi: 10.1007/BF02245874. Psychopharmacology (Berl). 1992. PMID: 1365627
-
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.Psychopharmacology (Berl). 2003 Sep;169(3-4):215-33. doi: 10.1007/s00213-003-1582-z. Epub 2003 Sep 2. Psychopharmacology (Berl). 2003. PMID: 12955285 Review.
-
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.Psychopharmacology (Berl). 2004 Jun;174(1):111-25. doi: 10.1007/s00213-003-1710-9. Epub 2004 Jan 20. Psychopharmacology (Berl). 2004. PMID: 15205882 Review.
-
Quinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection?Curr Org Chem. 2014 Jan 1;18(1):61-69. doi: 10.2174/138527281801140121123046. Curr Org Chem. 2014. PMID: 25346613 Free PMC article.
-
The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats.Psychopharmacology (Berl). 1995 Jul;120(2):156-61. doi: 10.1007/BF02246188. Psychopharmacology (Berl). 1995. PMID: 7480547